Skip to content

Opus Genetics IRD Cash Flow Statement

FY'25FY'24FY'23FY'22
-$49.59M+13.8%-$57.53M-476%-$9.99M-156%$17.89M+132%
$53K+430%$10K+66.7%$6K+50.0%$4K0.0%
$3.4M+1.1%$3.36M-4.2%$3.51M+94.2%$1.81M-5.6%
-$35.25M-37.8%-$25.58M$14.31M+174%
$0-100%$1.21M$0$0-100%
$0-100%$1.21M$0$0+100%
$50.02M+1,072%$4.27M-52.5%$8.98M+136%$3.8M-86.2%
-$20.18M$18.1M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Opus Genetics generate?
Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
Where does Opus Genetics's cash flow data come from?
Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.